United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar bez780 (< 20) Submitted: 7/29/2009 10:54:21 AM : Outperform Start Price: $42.96 UTHR Score: -33.63

new drugs

Featured Broker Partners


Advertisement